Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as
Three Arch Partners was formed in 1993 to provide young companies with access to relevant clinical and business resources, as well as capital. Three Arch has helped create, build and fund more than 100 important new healthcare companies. These companies have often become the clinical and market leaders in their respective fields, and have generated strong returns. The fund focuses on opportunities in medical devices and healthcare services, and less frequently in biotechnology.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 6, 2013
Ocera Therapeutics
|
Post-IPO Equity | $28M | Biopharma | — |
Jan 10, 2011
VisionCare Ophthalmic Technologies
|
Series E | $31M | Health Care | — |
Apr 2, 2007
Aspen MedTech
|
Series Unknown | $1M | Biotechnology | — |
Jan 4, 2005
VisionCare Ophthalmic Technologies
|
Series D | $20M | Health Care | — |
Nov 7, 2003
VisionCare Ophthalmic Technologies
|
Series C | $12.40M | Health Care | — |